Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
BACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.
Main Authors: | Beth E Davis, John K Reid, Donald W Cockcroft |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2003-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2003/148740 |
Similar Items
-
Tuberculous meningitis on directly observed thrice a week regime
by: Sora Yasri, et al.
Published: (2015-01-01) -
A comparison of practice pattern and outcome of twice-weekly and thrice-weekly hemodialysis patients
by: T Mukherjee, et al.
Published: (2017-01-01) -
Thrice-Weekly Nocturnal In-Centre Haemodiafiltration: A 2-Year Experience
by: Vishal Dey, et al.
Published: (2015-08-01) -
Anti-inflammatory and bronchoprotective roles of endogenous prostaglandin E2
by: Hiroki Sakakibara
Published: (1999-01-01) -
Major outcomes of patients with tuberculous meningitis on directly observed thrice a week regime
by: Thomas Iype, et al.
Published: (2014-01-01)